Aminoglycoside resistance by ArmA-mediated ribosomal 16S methylation in human bacterial pathogens

Journal of Molecular Biology
Grace F LiouMarc Galimand

Abstract

Aminoglycosides are a medically important class of antibiotics used to treat serious infections. Methylation of the ribosomal target is an emerging mechanism that produces a high level of resistance to all clinically available aminoglycosides for systemic therapy except streptomycin. ArmA was the first methyltransferase using this mechanism to be discovered in a clinical isolate. We demonstrate that ArmA methylates the N7 position of nucleotide G1405 in 16S rRNA. Methylation at this position is presumed to mediate cellular resistance by blocking aminoglycoside binding by ribosomes. To test this hypothesis, we measured the binding of gentamicin by 30S subunits. Under our conditions, we did not observe binding by ribosomes methylated by ArmA. Furthermore, the ArmA methylation reaction is specific for the 30S ribosomal subunit; neither 16S rRNA alone nor the 70S ribosome is a substrate for this reaction under our experimental conditions, implicating ribosomal proteins in substrate recognition. The biochemical characteristics of ArmA place it in the Agr family of methyltransferases, whose members are predominantly anti-suicide genes from Actinomycetes aminoglycoside producers. The discrepancy between the 30% GC content of armA and ...Continue Reading

References

Feb 20, 1987·Journal of Molecular Biology·A A Beauclerk, E Cundliffe
Jan 1, 1989·Annual Review of Microbiology·E Cundliffe
Nov 21, 1998·The EMBO Journal·S YoshizawaJ D Puglisi
Apr 24, 2003·Antimicrobial Agents and Chemotherapy·Sophie MagnetJohn S Blanchard
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Marc GalimandThierry Lambert
Dec 11, 2003·Microbiology and Molecular Biology Reviews : MMBR·Hiroshi Nikaido
Dec 12, 2003·Lancet·Keiko YokoyamaYoshichika Arakawa
Jan 27, 2004·Antimicrobial Agents and Chemotherapy·Yohei DoiYoshichika Arakawa
Feb 11, 2005·Chemical Reviews·Sophie Magnet, John S Blanchard
Jun 21, 2005·Emerging Infectious Diseases·Bruno González-ZornLucas Domínguez
Jun 28, 2005·Antimicrobial Agents and Chemotherapy·M GalimandT Lambert

❮ Previous
Next ❯

Citations

Dec 21, 2007·Archives of Microbiology·Patrice Courvalin
Jun 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yohei Doi, Yoshichika Arakawa
Feb 3, 2009·Nucleic Acids Research·Matthew R BakerJason P Rife
Apr 2, 2008·Antimicrobial Agents and Chemotherapy·Yohei DoiYoshichika Arakawa
May 2, 2012·Antimicrobial Agents and Chemotherapy·Marc GalimandThierry Lambert
Apr 7, 2010·Antimicrobial Agents and Chemotherapy·Margaret A DavisDouglas R Call
Feb 15, 2012·Antimicrobial Agents and Chemotherapy·Belen GutierrezBruno Gonzalez-Zorn
Oct 29, 2009·Cellular and Molecular Life Sciences : CMLS·Maulik ThakerGerard D Wright
Jun 8, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jun-ichi Wachino, Yoshichika Arakawa
Mar 24, 2009·Journal of Molecular Biology·Emmanuelle SchmittYves Mechulam
Nov 21, 2007·Transplantation Proceedings·A MłynarczykW Rowińnski
Oct 1, 2011·Wiley Interdisciplinary Reviews. RNA·Lisa S McCoyYitzhak Tor
Feb 3, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N MesarosF Van Bambeke
May 22, 2016·Infectious Disease Clinics of North America·Yohei DoiYoshichika Arakawa
May 29, 2012·ChemMedChem·Richard J FairYitzhak Tor
Mar 16, 2017·Antimicrobial Agents and Chemotherapy·Kellie Vinal, Graeme L Conn
Jan 17, 2007·The Journal of Antimicrobial Chemotherapy·Pierre BogaertsYouri Glupczynski
Oct 27, 2017·The Journal of Antibiotics·Yoshiaki Takahashi, Masayuki Igarashi
Mar 14, 2007·The Journal of Antimicrobial Chemotherapy·Lin ChenHong-Xia Jiang
Apr 29, 2020·Antibiotics·Rosalino Vázquez-LópezTomás Barrientos Fortes
Jun 5, 2020·Trends in Molecular Medicine·Adam J Schaenzer, Gerard D Wright
Sep 1, 2008·EcoSal Plus·Katherine S Long, Birte Vester
Aug 14, 2018·Microbiology Spectrum·Agnese LupoJean-Yves Madec
Apr 11, 2018·ACS Infectious Diseases·Georgina CoxGerard D Wright

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.